Armata director granted 51,280 stock options
Armata Pharmaceuticals director Daniel B. Gilmer received a grant of stock options for 51,280 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Armata Pharmaceuticals director Daniel B. Gilmer received a grant of stock options for 51,280 shares of common stock. The options have an exercise price of $12.92 per share and expire on April 24, 2036.
According to the terms, one-third of the underlying shares vest on each of the first, second, and third anniversaries of the April 24, 2026 grant date, as long as Gilmer continues to provide service through each vesting date. After this grant, he holds 51,280 stock options directly.
Insider Trade Summary
Grant/Award: 51,280 shares
Grant/Award
1 txn
Insider
Gilmer Daniel B.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 51,280 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to Buy) — 51,280 contracts (Direct)
Footnotes (1)
- F1. The Stock Option vests as to one-third of the underlying shares of common stock on each of the first, second and third annual anniversaries of the date of grant, subject to continuous service through the vesting date.
Key Figures
Options granted: 51,280 options
Exercise price: $12.92 per share
Expiration date: April 24, 2036
+2 more
5 metrics
Options granted
51,280 options
Stock options on common stock granted to director
Exercise price
$12.92 per share
Strike price for the granted stock options
Expiration date
April 24, 2036
Options expire on this date
Post-grant option holdings
51,280 options
Total options held directly after this grant
Vesting pattern
1/3 annually over 3 years
Subject to continuous service through each vesting date
Key Terms
Stock Options (Right to Buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Options (Right to Buy) financial
"security_title": "Stock Options (Right to Buy)""
exercise price financial
"conversion_or_exercise_price": "12.9200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The Stock Option vests as to one-third of the underlying shares"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date": "2036-04-24T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Armata Pharmaceuticals (ARMP) report for Daniel B. Gilmer?
Armata Pharmaceuticals reported that director Daniel B. Gilmer received a grant of stock options for 51,280 shares of common stock. These options are a form of equity compensation, not an open-market purchase, and give him the right to buy shares at a fixed price.
What is the exercise price of Daniel B. Gilmer’s new Armata Pharmaceuticals (ARMP) stock options?
The stock options granted to Daniel B. Gilmer have an exercise price of $12.92 per share. This is the fixed price at which he can buy Armata common stock if and when the options vest and he chooses to exercise them.
How do the newly granted Armata Pharmaceuticals (ARMP) options to Daniel B. Gilmer vest?
The options vest in three equal annual installments. One-third of the 51,280 underlying common shares vest on each of the first, second, and third anniversaries of the April 24, 2026 grant date, provided Gilmer continues in service through each vesting date.
When do Daniel B. Gilmer’s Armata Pharmaceuticals (ARMP) stock options expire?
The stock options granted to Daniel B. Gilmer expire on April 24, 2036. After this expiration date, any unexercised options will lapse, meaning he would no longer have the right to buy Armata common stock at the $12.92 exercise price.
How many Armata Pharmaceuticals (ARMP) options does Daniel B. Gilmer hold after this grant?
Following the reported grant, Daniel B. Gilmer holds 51,280 stock options directly. Each option represents the right to acquire one share of Armata common stock at the stated exercise price, subject to the vesting schedule and the stated expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates